Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Arcadia Biosciences, Inc. is a mediocre stock to choose.
Log in to see more information.
Arcadia Biosciences, Inc. is an agricultural biotechnology company which engages in the development...
RKDA Fundamental Data by TradingView

News

RKDA Stock Earnings: Arcadia Biosciences Misses EPS, Beats Revenue for Q2 2024
RKDA Stock Earnings: Arcadia Biosciences Misses EPS, Beats Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nRKDA stock results show that Arcadia Biosciences missed analyst estimates for earnings per share but beat on revenue for the second...\n more…

Arcadia Biosciences (RKDA) Q2 Earnings Miss Estimates
Arcadia Biosciences (RKDA) Q2 Earnings Miss Estimates

Zacks Investment Research Arcadia Biosciences (RKDA) came out with quarterly earnings of $0.78 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to loss of $2.64 per share a year ago. These...\n more…

Arcadia Biosciences reports Q2 EPS 78cs vs 61c last year
Arcadia Biosciences reports Q2 EPS 78cs vs 61c last year

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights
Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights

Business Wire Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and...\n more…

Hydrofarm Holdings Group, Inc. (HYFM) Reports Q2 Loss, Tops Revenue Estimates
Hydrofarm Holdings Group, Inc. (HYFM) Reports Q2 Loss, Tops Revenue Estimates

Zacks Investment Research Hydrofarm Holdings Group, Inc. (HYFM) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.21 per share a year ago...\n more…

Arcadia Biosciences Appoints Thomas Schaefer as Class I Director
Arcadia Biosciences Appoints Thomas Schaefer as Class I Director

TipRanks Financial Blog An update from Arcadia Biosciences (RKDA) is now available. Arcadia Biosciences, Inc. has elevated Thomas J. Schaefer to a Class I director position following Stanl...\n more…